422 related articles for article (PubMed ID: 10403323)
1. Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated from Egyptian villagers.
Ismail M; Botros S; Metwally A; William S; Farghally A; Tao LF; Day TA; Bennett JL
Am J Trop Med Hyg; 1999 Jun; 60(6):932-5. PubMed ID: 10403323
[TBL] [Abstract][Full Text] [Related]
2. Characterization of isolates of Schistosoma mansoni from Egyptian villagers that tolerate high doses of praziquantel.
Ismail M; Metwally A; Farghaly A; Bruce J; Tao LF; Bennett JL
Am J Trop Med Hyg; 1996 Aug; 55(2):214-8. PubMed ID: 8780463
[TBL] [Abstract][Full Text] [Related]
3. Anti-schistosomal drugs: observations on the mechanism of drug resistance to hycanthone, and on the involvement of host antibodies in the mode of action of praziquantel.
Brindley PJ; Sher A
Mem Inst Oswaldo Cruz; 1987; 82 Suppl 4():157-61. PubMed ID: 3151089
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo activity of R- and S- praziquantel enantiomers and the main human metabolite trans-4-hydroxy-praziquantel against Schistosoma haematobium.
Kovač J; Vargas M; Keiser J
Parasit Vectors; 2017 Aug; 10(1):365. PubMed ID: 28764732
[TBL] [Abstract][Full Text] [Related]
5. Resistance of Schistosoma mansoni to praziquantel: is there a problem?
Doenhoff MJ; Kusel JR; Coles GC; Cioli D
Trans R Soc Trop Med Hyg; 2002; 96(5):465-9. PubMed ID: 12474468
[TBL] [Abstract][Full Text] [Related]
6. Activity of praziquantel enantiomers and main metabolites against Schistosoma mansoni.
Meister I; Ingram-Sieber K; Cowan N; Todd M; Robertson MN; Meli C; Patra M; Gasser G; Keiser J
Antimicrob Agents Chemother; 2014 Sep; 58(9):5466-72. PubMed ID: 24982093
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a method for induction of praziquantel resistance in Schistosoma mansoni.
Lotfy WM; Hishmat MG; El Nashar AS; Abu El Einin HM
Pharm Biol; 2015 Aug; 53(8):1214-9. PubMed ID: 25609146
[TBL] [Abstract][Full Text] [Related]
8. Laboratory induced resistance to praziquantel in experimental schistosomiasis.
Ismail MM; Taha SA; Farghaly AM; el-Azony AS
J Egypt Soc Parasitol; 1994 Dec; 24(3):685-95. PubMed ID: 7844435
[TBL] [Abstract][Full Text] [Related]
9. Genetic analysis of praziquantel resistance in Schistosoma mansoni.
Liang YS; Dai JR; Zhu YC; Coles GC; Doenhoff MJ
Southeast Asian J Trop Med Public Health; 2003 Jun; 34(2):274-80. PubMed ID: 12971549
[TBL] [Abstract][Full Text] [Related]
10. Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific.
Fallon PG; Doenhoff MJ
Am J Trop Med Hyg; 1994 Jul; 51(1):83-8. PubMed ID: 8059919
[TBL] [Abstract][Full Text] [Related]
11. Altered response of strain of Schistosoma mansoni to oxamniquine and praziquantel.
Bonesso-Sabadini PI; de Souza Dias LC
Mem Inst Oswaldo Cruz; 2002 Apr; 97(3):381-5. PubMed ID: 12048569
[TBL] [Abstract][Full Text] [Related]
12. Modulation of the antioxidant defence in different developmental stages of Schistosoma mansoni by praziquantel and artemether.
El-Bassiouni EA; Helmy MH; Saad EI; El-Nabi Kamel MA; Abdel-Meguid E; Hussein HS
Br J Biomed Sci; 2007; 64(4):168-74. PubMed ID: 18236739
[TBL] [Abstract][Full Text] [Related]
13. THE SUSCEPTIBILITY OF RECENT ISOLATES OF Schistosoma mansoni TO PRAZIQUANTEL.
Mendonça AM; Feitosa AP; Veras DL; Matos-Rocha TJ; Cavalcanti MG; Barbosa CC; Brayner FA; Alves LC
Rev Inst Med Trop Sao Paulo; 2016; 58():7. PubMed ID: 26910445
[TBL] [Abstract][Full Text] [Related]
14. Adult worm tegumental damage and egg-granulomas in praziquantel-resistant and -susceptible Schistosoma mansoni treated in vivo.
Liang YS; Coles GC; Dai JR; Zhu YC; Doenhoff MJ
J Helminthol; 2002 Dec; 76(4):327-33. PubMed ID: 12498638
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic efficacy of candidate antischistosomal drugs in a murine model of schistosomiasis mansoni.
Mohammad OS; Hussein HM; Abdel-Sayed SW; Mohamed GA; Shehata MAS
Parasitol Res; 2024 May; 123(5):215. PubMed ID: 38771511
[TBL] [Abstract][Full Text] [Related]
16. In vivo schistosomicidal activity of three novels 8-hydroxyquinoline derivatives against adult and immature worms of Schistosoma mansoni.
Allam G; Eweas AF; Abuelsaad AS
Parasitol Res; 2013 Sep; 112(9):3137-49. PubMed ID: 23793335
[TBL] [Abstract][Full Text] [Related]
17. Variation in response of Schistosoma mansoni strains to schistosomicides.
Dias LC; Bruce JI; Coles GC
Rev Inst Med Trop Sao Paulo; 1988; 30(2):81-5. PubMed ID: 3144034
[No Abstract] [Full Text] [Related]
18. Immune-dependent chemotherapy of schistosomiasis.
Fallon PG; Cooper RO; Probert AJ; Doenhoff MJ
Parasitology; 1992; 105 Suppl():S41-8. PubMed ID: 1308928
[TBL] [Abstract][Full Text] [Related]
19. Use of kinase inhibitors against schistosomes to improve and broaden praziquantel efficacy.
Nawaratna SSK; McManus DP; Gasser RB; Brindley PJ; Boyle GM; Rivera V; Ranasinghe SL; Jones MK; You H; Gobert GN
Parasitology; 2020 Nov; 147(13):1488-1498. PubMed ID: 32741402
[TBL] [Abstract][Full Text] [Related]
20. The Role of Efflux Pumps in Schistosoma mansoni Praziquantel Resistant Phenotype.
Pinto-Almeida A; Mendes T; Armada A; Belo S; Carrilho E; Viveiros M; Afonso A
PLoS One; 2015; 10(10):e0140147. PubMed ID: 26445012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
